Document is current
Any future updates will be listed below
-
Authors
Grannell, Andrew http://orcid.org/0000-0001-9529-511X
le Roux, Carel http://orcid.org/0000-0001-5521-5445
- License Information
-
More Information
Article History
Received: 29 February 2024
Revised: 24 June 2024
Accepted: 2 July 2024
First Online: 10 July 2024
Competing interests
: AG declares no competing interests. CLR receives grants from Anabio and serves on advisory boards of Novo Nordisk, Herbalife, GI Dynamics, Eli Lilly, Johnson & Johnson, Glia, Keyron, and Boehringer Ingelheim.
